Evotec SE (FRA:EVT)
5.57
+0.06 (1.12%)
Last updated: Dec 4, 2025, 9:00 AM CET
Evotec SE Revenue
Evotec SE had revenue of 163.89M EUR in the quarter ending September 30, 2025, a decrease of -11.36%. This brings the company's revenue in the last twelve months to 756.33M, down -2.67% year-over-year. In the year 2024, Evotec SE had annual revenue of 796.97M with 1.99% growth.
Revenue (ttm)
756.33M
Revenue Growth
-2.67%
P/S Ratio
1.27
Revenue / Employee
157.96K
Employees
4,740
Market Cap
962.15M
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 796.97M | 15.54M | 1.99% |
| Dec 31, 2023 | 781.43M | 29.98M | 3.99% |
| Dec 31, 2022 | 751.45M | 133.41M | 21.59% |
| Dec 31, 2021 | 618.03M | 117.11M | 23.38% |
| Dec 31, 2020 | 500.92M | 54.49M | 12.20% |
| Dec 31, 2019 | Pro | Pro | Pro |
| Dec 31, 2018 | Pro | Pro | Pro |
| Dec 31, 2017 | Pro | Pro | Pro |
| Dec 31, 2016 | Pro | Pro | Pro |
| Dec 31, 2015 | Pro | Pro | Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| SAP SE | 36.49B |
| Siemens Aktiengesellschaft | 78.91B |
| Allianz SE | 105.02B |
| Deutsche Telekom AG | 121.02B |
| Siemens Energy AG | 39.08B |
| Rheinmetall AG | 11.00B |
| Münchener Rückversicherungs-Gesellschaft Aktiengesellschaft in München | 62.10B |
| Deutsche Bank Aktiengesellschaft | 29.86B |
Evotec SE News
- 7 days ago - EQS-NVR: Evotec SE: Release according to Article 41 of the WpHG [the German Securities Trading Act] with the objective of Europe-wide distribution - Wallstreet:Online
- 11 days ago - EQS-PVR: Evotec SE: Release according to Article 40, Section 1 of the WpHG [the German Securities Trading Act] with the objective of Europe-wide distribution - Wallstreet:Online
- 22 days ago - EQS-DD: Evotec SE: Wesley Wheeler, buy - Wallstreet:Online
- 23 days ago - Evotec (EVO) Secures $5M Milestone from Bristol Myers Squibb - GuruFocus
- 23 days ago - Evotec gets $5M milestone payment from Bristol Myers after FDA accepts new drug application - Seeking Alpha
- 23 days ago - Evotec Receives Milestone Payment from Bristol Myers Squibb Following IND Acceptance in Strategic Protein Degradation Partnership - Accesswire
- 23 days ago - Evotec Hits Milestone with Bristol Myers Squibb in Protein Partnership - Wallstreet:Online
- 4 weeks ago - Evotec SE 2025 Q3 - Results - Earnings Call Presentation - Seeking Alpha